BRCA1 and neoplasm: Gene expression–based immune infiltration, assessed by ConsensusTME (33) average score, was lower in BRCA1 mutated and BRCA1 methylated tumours compared with BRCA1/2 wild-type (P = 0.040; Fig. 2B) but did not differ according to HRD status (P = 0.720; Supplementary Fig. S1E).